Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Trial of Celecoxib in Persons with Genotype Positiv-261005126
University of Texas MD Anderson Cancer Center
Search grants from University of Texas MD Anderson Cancer Center
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Histopathology Core
Cervical Spine Injuries in Front, Rear and Side Impacts
Mixture Toxicity - Evaluation of an Improved Methodology
Neurological Sciences Academic Development Award
Role of Oncogenes in the Pathogenesis of Melanoma
Recently added grants:
Elucidating the relationship between lipid droplets, lipid metabolism, and lipotoxicity
Basement Membrane Targeted Nanoparticles for Post-Surgical Adhesion Prevention
Molecular mechanisms controlling kinetochore-microtubule attachments during mitosis
Regulation Of Metabolism And Gene Expression By Iron-Sulfur Clusters - Resubmission - 1
Cord Blood Adductomics in Bronchopulmonary Dysplasia
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN005126-003
Application #
7191425
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2005
Total Cost
Indirect Cost
Institution
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CN
Phase II Clinical Trial of Celecoxib in Persons with Genotype Positiv-261005126
/ University of Texas MD Anderson Cancer Center
NIH 2005
N01 CN
Phase II Clinical Trial of Celecoxib in Persons with Genotype Positiv-261005126
/ University of Texas MD Anderson Cancer Center
NIH 2004
N01 CN
Phase II Clinical Trial of Celecoxib in Persons with Genotype Positiv-261005126
/ University of Texas MD Anderson Cancer Center
NIH 2000
N01 CN
Phase II Clinical Trial of Celecoxib in Persons with Ge
Lynch, Patrick M. / University of Texas MD Anderson Cancer Center
$3,251,125
Publications
Lynch, Patrick M; Ayers, Gregory D; Hawk, Ernie et al.
(2010)
The safety and efficacy of celecoxib in children with familial adenomatous polyposis.
Am J Gastroenterol 105:1437-43
Comments
Be the first to comment on this grant